Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
The AI Power Struggle Is Out of Silicon Valley's Control
Anthropic PBC's latest complaint against three Chinese labs is a warning sign for Silicon Valley: Don't expect to earn too much from the competitive edge your model gives you. Companies from the developing world will line up to swim across your…
Monashee Investment Management LLC Lowers Holdings in BridgeBio Pharma, Inc. $BBIO
Monashee Investment Management LLC lessened its stake in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 21.6% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange…
Karl Stefanovic apologises for role in Channel Nine's vaccine campaign
Karl Stefanovic has revealed that he now regrets urging Aussies to get the Covid jab during the pandemic. The Today Show co-cost made the admission during a wide-ranging interview with former Liberal senator and outspoken vaccine critic Gerard…
I'm a Brit trapped in Dubai with kids cowering from smoke and eerie bangs
Saturdays in Dubai usually are a time for sun, shopping and brunches - not bombs and missiles. But as the mercury hit 28C yesterday afternoon, the Emirates city - named 2025's 'second safest in the world ' - was transformed into a zone of terror as…
Cinde Warmington pushes back on opioid lobbying attacks, blames Kelly Ayotte | CloseUp
Cinde Warmington pushes back on opioid lobbying attacks, blames Kelly Ayotte | CloseUp CREMATIONS.COM OR CALL (603) 524-1425. WELCOME BACK TO CLOSE UP THE RACE FOR GOVERNOR. GOT SOME CLARITY OVER THE LAST FEW DAYS AS PORTSMOUTH MAYOR MCCACHREN…
[Ad hoc announcement pursuant to Art. 53 LR] Roche's fenebrutinib confirms its potential as first and only BTK inhibitor for relapsing and primary progressive MS in third positive Phase III study (FENhance 1)
FENhance 1 met its primary endpoint, showing investigational fenebrutinib significantly reduced relapses by 51% compared to teriflunomide in relapsing multiple sclerosis (RMS), consistent with FENhance 2 results showing 59% reduction FENhance 1 is…
Should You Forget Eli Lilly and Buy This Magnificent High-Yield Dividend Stock Instead?
Eli Lilly (LLY +2.93%) is growing very quickly right now thanks to Mounjaro and Zepbound, its two GLP-1 drugs, the latter of which is approved for weight loss. Mounjaro's sales rose 99% in 2025, and Zepbound's sales were up a shocking 175%. But…
NHS wonder drug saved my sick lungs - now I'm running a marathon
The Express started campaigning for CF sufferers in February 2019 and by October of that year the first two main drugs by US pharma giant Vertex - Orkambi and Symkevi - became available to UK patients. By the summer of 2020 the third wonder…
PM Modi Targets Congress, Says Oppn Party Worked as 'Speedbreaker' in Puducherry's Growth
Puducherry: Prime Minister Narendra Modi, on Sunday, took aim at the Congress and said that the opposition party had created a 'speedbreaker in the growth of Puducherry'. Years of Congress rule were marked by corruption, crime and suffering of the…
Giro di Sardegna: Filippo Zana takes home overall victory as Davide Donati speeds to final stage win
It was double Italian victory in the Giro di Sardegna on Sunday, with Filippo Zana (Soudal-QuickStep) sealing the GC title after his Queen stage triumph, whilst Davide Donati (Red Bull-Bora-Hansgrohe Rookies) conquered the final sprint. Donati came…
Media Buying Briefing: The Big Three's pieces are in place - let's see who wins
Observers note the similarity to Publicis' Power of One model, given that WPP has made its Open platform the connective tissue among the four divisions. Even the Enterprise Solutions unit appears to emulate Publicis' Sapient in its bid to offer…
Best Growth Stocks To Watch Today - March 1st
3 Under-the-Radar AI Infrastructure Stocks Powering the Next Buildout Prologis, Teledyne Technologies, Ascendis Pharma A/S, Hercules Capital, and Hamilton Lane are the five Growth stocks to watch today, according to MarketBeat's stock screener…
ON THE PERIPHERY | Immigration Status as a Health Determinant
In the past year, there has been a lot of news and discourse over undocumented immigrants, civil rights, and immigration enforcement in the United States. A more neglected question is that of immigrant healthcare. I'm sure we have all, to some…
What To Read This Weekend
Okay, this might be the N+1 attempt to rekindle this newsletter format. I start with good intentions, but always fail at maintaining continuity. I am going to give this one more try, and see how it goes. As Yoda said, “Do. Or do not. There…
Measuring what matters: one standard for greener healthcare
Europe's ambition to become climate neutral by 2050 cannot succeed in healthcare unless we fix a basic problem: we do not measure sustainability in the same way across the single market. Currently, measuring Product Carbon Footprints (PCF) and Life…
Receive a Daily briefing on Pharma Industry News
Get Started